Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
A. Michael Lincoff(Cleveland Clinic), Donna H. Ryan(Pennington Biomedical Research Center), Helen M. Colhoun(Edinburgh Cancer Research), John Deanfield(Universidad de Londres), Jorge Plutzky(Brigham and Women's Hospital), Tuğçe Kalaycı Oral(Cleveland Clinic Lerner College of Medicine), Sille Esbjerg(Cleveland Clinic Lerner College of Medicine), Steven E. Kahn(VA Puget Sound Health Care System), Søren Hardt‐Lindberg(Cleveland Clinic Lerner College of Medicine), Scott S. Emerson(Cleveland Clinic Lerner College of Medicine), Marie Mide Michelsen(Novo Nordisk (Denmark)), Kirstine Brown‐Frandsen(Cleveland Clinic Lerner College of Medicine), Robert F. Kushner(Cleveland Clinic Lerner College of Medicine), Ildiko Lingvay(Southwestern Medical Center), Christoffer W. Tornøe(Cleveland Clinic Lerner College of Medicine), G. Kees Hovingh(Novo Nordisk (Denmark))
Cited by 2,572
Related Papers
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
|The Lancet|1992|4.8k
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery
|Journal of the American College of Cardiology|2002|4.6k
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
|Journal of the American College of Cardiology|2013|4k
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
|The Lancet|2004|3.8k
Atherosclerosis
|Nature Reviews Disease Primers|2019|3k